Keith T. Flaherty - 10 Jun 2021 Form 4 Insider Report for Clovis Oncology, Inc. (CLVS)

Role
Director
Signature
/s/ Keith Flaherty
Issuer symbol
CLVS
Transactions as of
10 Jun 2021
Transactions value $
$0
Form type
4
Filing time
11 Jun 2021, 21:02:15
Next filing
14 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLVS Stock Option (right to buy) Award $0 +42.2K $0.00 42.2K 10 Jun 2021 Common Stock 42.2K $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on the one-year anniversary of the date of grant.